IBDEI1AQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22038,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,22038,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,22039,0)
 ;;=E27.1^^87^973^51
 ;;^UTILITY(U,$J,358.3,22039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22039,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,22039,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,22039,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,22040,0)
 ;;=E27.2^^87^973^1
 ;;^UTILITY(U,$J,358.3,22040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22040,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,22040,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,22040,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,22041,0)
 ;;=E27.3^^87^973^23
 ;;^UTILITY(U,$J,358.3,22041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22041,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,22041,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,22041,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,22042,0)
 ;;=E29.1^^87^973^52
 ;;^UTILITY(U,$J,358.3,22042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22042,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,22042,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,22042,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,22043,0)
 ;;=E55.9^^87^973^59
 ;;^UTILITY(U,$J,358.3,22043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22043,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,22043,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,22043,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,22044,0)
 ;;=E66.01^^87^973^38
 ;;^UTILITY(U,$J,358.3,22044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22044,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,22044,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,22044,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,22045,0)
 ;;=E66.8^^87^973^42
 ;;^UTILITY(U,$J,358.3,22045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22045,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,22045,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,22045,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,22046,0)
 ;;=E66.9^^87^973^43
 ;;^UTILITY(U,$J,358.3,22046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22046,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,22046,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,22046,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,22047,0)
 ;;=E74.39^^87^973^35
 ;;^UTILITY(U,$J,358.3,22047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22047,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,22047,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,22047,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,22048,0)
 ;;=E83.30^^87^973^46
 ;;^UTILITY(U,$J,358.3,22048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22048,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,22048,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,22048,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,22049,0)
 ;;=E83.51^^87^973^28
 ;;^UTILITY(U,$J,358.3,22049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22049,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,22049,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,22049,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,22050,0)
 ;;=E83.52^^87^973^26
 ;;^UTILITY(U,$J,358.3,22050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22050,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,22050,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,22050,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,22051,0)
 ;;=E87.5^^87^973^27
 ;;^UTILITY(U,$J,358.3,22051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22051,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,22051,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,22051,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,22052,0)
 ;;=E89.2^^87^973^48
